RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: acute kidney failure
Accession: DOID:3021
browse the term
Definition: Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.
Synonyms: exact_synonym: Acute Kidney Failures; Acute Kidney Injuries; Acute Kidney Injury; Acute Kidney Insufficiencies; Acute Kidney Insufficiency; Acute Renal Failure; Acute Renal Failures; Acute Renal Injuries; Acute Renal Injury; Acute Renal Insufficiencies; Acute Renal Insufficiency
narrow_synonym: post-operative acute kidney injury; postoperative acute kidney injury
primary_id: MESH:D058186 ; RDO:0001702
xref: EFO:0009955
For additional species annotation, visit the
Alliance of Genome Resources .
G
A2m
alpha-2-macroglobulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23052191
NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186
G
Ace
angiotensin I converting enzyme
treatment
ISO
RGD
PMID:24502693
RGD:11039053
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Adrb2
adrenergic receptor, beta 2
treatment
ISO
associated with endotoxemia; protein:increased expression:kidney associated with Endotoxemia; associated with Bacteremia;
RGD
PMID:14747378 PMID:19020966 PMID:19887504 PMID:14747378
RGD:7175276 , RGD:7175283 , RGD:7175281 , RGD:7175276
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
G
Afm
afamin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 5:90,666,808...90,701,403
Ensembl chr 5:90,666,791...90,701,402
G
Ager
advanced glycosylation end product-specific receptor
ISO
RGD
PMID:21811803
RGD:7243868
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Ahsg
alpha-2-HS-glycoprotein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr16:22,710,793...22,718,193
Ensembl chr16:22,710,027...22,718,199
G
Alad
aminolevulinate, delta-, dehydratase
ISO
protein:decreased activity:kidney (rat)
RGD
PMID:19484701
RGD:4144146
NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155
G
Alb
albumin
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:2048579 PMID:21259293 PMID:24361871 PMID:28885000
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Alox5
arachidonate 5-lipoxygenase
ISO
RGD
PMID:19194548
RGD:2317536
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
G
Ambp
alpha 1 microglobulin/bikunin precursor
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:8963945 PMID:28885000 PMID:8963945
RGD:6904218
NCBI chr 4:63,061,512...63,072,409
Ensembl chr 4:63,061,512...63,073,036
G
Amn
amnionless
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20514524
NCBI chr12:111,237,530...111,242,860
Ensembl chr12:111,237,529...111,242,860
G
Anxa1
annexin A1
treatment
ISO
RGD
PMID:22101490
RGD:7421583
NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308
G
Ar
androgen receptor
ISO
RGD
PMID:24503548
RGD:11570523
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Arg1
arginase, liver
ISO
mRNA:decreased expression:renal tubule (rat)
RGD
PMID:12371970
RGD:631989
NCBI chr10:24,791,105...24,803,368
Ensembl chr10:24,791,119...24,803,382
G
Arg2
arginase type II
ISO
mRNA:decreased expression:renal tubule (rat)
RGD
PMID:12371970
RGD:631989
NCBI chr12:79,177,562...79,203,075
Ensembl chr12:79,177,551...79,203,075
G
Atp5f1b
ATP synthase F1 subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25666834
NCBI chr10:127,919,176...127,926,257
Ensembl chr10:127,919,142...127,926,260
G
Avp
arginine vasopressin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2139164
NCBI chr 2:130,422,540...130,424,508
Ensembl chr 2:130,422,540...130,424,474
G
Avpr1a
arginine vasopressin receptor 1A
ISO
RGD
PMID:17347933
RGD:2300348
NCBI chr10:122,284,404...122,289,358
Ensembl chr10:122,284,404...122,289,357
G
Azgp1
alpha-2-glycoprotein 1, zinc
disease_progression
ISO
RGD
PMID:23849457
RGD:153350150
NCBI chr 5:137,979,783...137,988,495
Ensembl chr 5:137,979,782...137,988,495
G
B2m
beta-2 microglobulin
ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:2689182 PMID:22005293 PMID:28885000 PMID:19536607
RGD:6482685
NCBI chr 2:121,978,168...121,983,563
Ensembl chr 2:121,978,167...121,983,564
G
Bad
BCL2-associated agonist of cell death
treatment
ISO
RGD
PMID:20037173
RGD:10053672
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
G
Bax
BCL2-associated X protein
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20623750 PMID:20037173
RGD:10053672
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
ISO
protein:increased expression:kidney
RGD
PMID:20037173
RGD:10053672
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bcl2l1
BCL2-like 1
ISO
protein:increased expression:kidney
RGD
PMID:20037173
RGD:10053672
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Bdkrb2
bradykinin receptor, beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24975837
NCBI chr12:105,529,431...105,561,503
Ensembl chr12:105,529,485...105,561,496
G
C3
complement component 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Capn1
calpain 1
treatment
ISO
associated with Rhabdomyolysis;
RGD
PMID:24158126
RGD:13792553
NCBI chr19:6,038,573...6,065,855
Ensembl chr19:6,038,573...6,065,927
G
Casp1
caspase 1
ISO
RGD
PMID:16557226
RGD:2293624
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
G
Ccl11
C-C motif chemokine ligand 11
IEP
protein:increased expression:kidney
RGD
PMID:22778179
RGD:7247739
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
G
Ccl3
C-C motif chemokine ligand 3
ISO
RGD
PMID:20482449
RGD:6906908
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
G
Ccl5
C-C motif chemokine ligand 5
IEP
protein:increased secretion:serum (mouse)
RGD
PMID:19508392
RGD:4889990
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Ccr5
C-C motif chemokine receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26055553
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
G
Cct7
chaperonin containing TCP1 subunit 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31825490
NCBI chr 6:85,428,487...85,445,459
Ensembl chr 6:85,428,496...85,445,457
G
Cd44
CD44 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23052191
NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010
G
Cdkn1b
cyclin dependent kinase inhibitor 1B
ISO
protein:decreased expression:kidney
RGD
PMID:16557226
RGD:2293624
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
G
Ces1c
carboxylesterase 1C
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 8:93,825,643...93,857,911
Ensembl chr 8:93,825,643...93,857,911
G
Clu
clusterin
ISO
protein:increased expression:urine CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20118187 PMID:20623750 PMID:22005293 PMID:23052191 PMID:24361871 PMID:28885000 PMID:22581811 More...
RGD:7245501
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
G
Cp
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309
G
Crp
C-reactive protein, pentraxin-related
ISO
protein:increased expression:serum associated with Myocardial Infarction;
RGD
PMID:22551254 PMID:22694718
RGD:6903282 , RGD:6906888
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Csf1
colony stimulating factor 1 (macrophage)
IMP
RGD
PMID:23143303
RGD:7257565
NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
G
Csf1r
colony stimulating factor 1 receptor
IMP
RGD
PMID:23143303
RGD:7257565
NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221
G
Cst3
cystatin C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22005293 PMID:28885000
NCBI chr 2:148,713,642...148,717,432
Ensembl chr 2:148,713,642...148,717,612
G
Cxcl1
C-X-C motif chemokine ligand 1
IEP
mRNA:increased expression:kidney, liver, spleen
RGD
PMID:21677145
RGD:7175314
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
treatment
IDA
RGD
PMID:19890363 PMID:18495746
RGD:7257732 , RGD:7257735
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
treatment
IDA
RGD
PMID:23981375 PMID:18495746
RGD:7257727 , RGD:7257735
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp27b1
cytochrome P450, family 27, subfamily b, polypeptide 1
ISO
RGD
PMID:6223803
RGD:2307326
NCBI chr10:126,884,115...126,891,897
Ensembl chr10:126,884,119...126,888,875
G
Cyp2c38
cytochrome P450, family 2, subfamily c, polypeptide 38
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19814645
NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
G
Cyp2c65
cytochrome P450, family 2, subfamily c, polypeptide 65
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19814645
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
G
Cyp2d22
cytochrome P450, family 2, subfamily d, polypeptide 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19814645
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
treatment
ISO
RGD
PMID:24717297 PMID:24412858
RGD:14700914 , RGD:14700920
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Ddit3
DNA-damage inducible transcript 3
ISO
Protein:increased expression:renal tubule epithelium
RGD
PMID:15476864
RGD:1599736
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
G
Dll4
delta like canonical Notch ligand 4
ameliorates
IDA
RGD
PMID:19828677
RGD:155663373
NCBI chr 2:119,156,286...119,166,145
Ensembl chr 2:119,156,265...119,166,443
G
Ece1
endothelin converting enzyme 1
ISO
RGD
PMID:11043448 PMID:10073607
RGD:7244180 , RGD:7244185
NCBI chr 4:137,589,548...137,692,540
Ensembl chr 4:137,589,548...137,692,540
G
Edn1
endothelin 1
IEP ISO
mRNA, protein:increased expression:kidney (mouse) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9788586 PMID:19967049
RGD:4144852
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Egf
epidermal growth factor
ISO
mRNA:decreased expression:kidney
RGD
PMID:20482449 PMID:11340354
RGD:6906908 , RGD:10395241
NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
G
Egfr
epidermal growth factor receptor
ISO
mRNA:increased expression:kidney CTD Direct Evidence: therapeutic
CTD RGD
PMID:14638913 PMID:11340354
RGD:10395241
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
G
Egln1
egl-9 family hypoxia-inducible factor 1
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:19349364
RGD:11252083
NCBI chr 8:125,635,325...125,676,063
Ensembl chr 8:125,635,326...125,676,063
G
Egln3
egl-9 family hypoxia-inducible factor 3
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:19349364
RGD:11252083
NCBI chr12:54,225,767...54,250,660
Ensembl chr12:54,225,767...54,250,646
G
Epas1
endothelial PAS domain protein 1
treatment
ISO
RGD
PMID:16762988
RGD:10395386
NCBI chr17:87,061,292...87,140,838
Ensembl chr17:87,061,128...87,140,838
G
Ephx2
epoxide hydrolase 2, cytoplasmic
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26165641
NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949
G
Epo
erythropoietin
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:21847101 PMID:24561306 PMID:22209169 PMID:22235348
RGD:10400913 , RGD:11041660
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
G
Fas
Fas cell surface death receptor
ISO
protein:increased expression:renal tubule (rat)
RGD
PMID:21374789
RGD:8663469
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fga
fibrinogen alpha chain
ISO
mRNA:increased expression:kidney (rat)
RGD
PMID:15805072
RGD:9685024
NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
G
Fis1
fission, mitochondrial 1
ISO
protein:decreased expression:kidney (rat)
RGD
PMID:26480480
RGD:12910862
NCBI chr 5:136,982,129...136,995,088
Ensembl chr 5:136,982,129...136,995,088
G
Fn1
fibronectin 1
ISO
protein:increased expression:kidney
RGD
PMID:12884040 PMID:11768240
RGD:7205684 , RGD:729934
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
G
Fstl1
follistatin-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20861081
NCBI chr16:37,597,417...37,656,878
Ensembl chr16:37,597,235...37,656,876
G
G6pdx
glucose-6-phosphate dehydrogenase X-linked
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:602954 PMID:734759 PMID:4794122
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
G
Gas6
growth arrest specific 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19564549
NCBI chr 8:13,515,374...13,544,535
Ensembl chr 8:13,515,374...13,544,490
G
Gatm
glycine amidinotransferase (L-arginine:glycine amidinotransferase)
ISO
protein:decreased activity:kidney (rat)
RGD
PMID:2752493
RGD:1599823
NCBI chr 2:122,424,954...122,441,758
Ensembl chr 2:122,424,948...122,441,784
G
Gc
vitamin D binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
G
Gfer
growth factor, augmenter of liver regeneration
treatment
ISO
protein:increased expression:cortex of kidney,renal medulla: CTD Direct Evidence: therapeutic
CTD RGD
PMID:20030531 PMID:20030531 PMID:20030531
RGD:9685736 , RGD:9685736
NCBI chr17:24,912,164...24,915,065
Ensembl chr17:24,912,161...24,915,130
G
Ghrl
ghrelin
IDA
RGD
PMID:19625378
RGD:7242430
NCBI chr 6:113,693,080...113,696,872
Ensembl chr 6:113,693,080...113,696,841
G
Got2
glutamatic-oxaloacetic transaminase 2, mitochondrial
ISO
protein:decreased activity:kidney (rat)
RGD
PMID:23924727
RGD:13506245
NCBI chr 8:96,590,761...96,615,029
Ensembl chr 8:96,590,762...96,615,175
G
Gpnmb
glycoprotein (transmembrane) nmb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23052191
NCBI chr 6:49,013,449...49,044,413
Ensembl chr 6:49,013,480...49,047,863
G
Gpt
glutamic pyruvic transaminase, soluble
treatment
ISO
RGD
PMID:22209169
RGD:10400913
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Gpx3
glutathione peroxidase 3
ISO
protein:decreased expression:kidney
RGD
PMID:36583727
RGD:401827125
NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
G
Gpx4
glutathione peroxidase 4
treatment
ISO
RGD
PMID:29548851
RGD:401827911
NCBI chr10:79,883,000...79,892,273
Ensembl chr10:79,883,000...79,892,273
G
Gsk3b
glycogen synthase kinase 3 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22785175
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
G
Gsr
glutathione reductase
ISO IEP
glycerol-induced protein:decreased activity:kidney:
RGD
PMID:1870354 PMID:22286819
RGD:7257559 , RGD:7257585
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Gstm2
glutathione S-transferase, mu 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 3:107,889,018...107,893,736
Ensembl chr 3:107,889,018...107,893,769
G
Gstp1
glutathione S-transferase, pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20623750 PMID:20798258
RGD:6903954
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Havcr1
hepatitis A virus cellular receptor 1
ISO IEP
protein:increased expression:urine CTD Direct Evidence: marker/mechanism protein:increased expression:urine: associated with Pyelonephritis;protein:increased expression:urine:
CTD RGD
PMID:20118187 PMID:21259293 PMID:21835770 PMID:22005293 PMID:23052191 PMID:23845967 PMID:24189134 PMID:24361871 PMID:24958931 PMID:28885000 PMID:23683031 PMID:23019274 PMID:23319831 More...
RGD:7244370 , RGD:7245495 , RGD:7245472
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
G
Hbegf
heparin-binding EGF-like growth factor
ISO
mRNA:increased expression:kidney CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:7635938 PMID:11340354
RGD:10395241
NCBI chr18:36,637,980...36,648,858
Ensembl chr18:36,637,980...36,648,858
G
Hdac2
histone deacetylase 2
treatment
IEP
associated with sepsis;
RGD
PMID:22933299
RGD:9590257
NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885
G
Hdac3
histone deacetylase 3
ISO
RGD
PMID:21416250
RGD:10047111
NCBI chr18:38,070,024...38,088,073
Ensembl chr18:38,068,897...38,088,069
G
Hdac5
histone deacetylase 5
treatment
IEP ISO
associated with sepsis;
RGD
PMID:22933299 PMID:21416250
RGD:9590257 , RGD:10047111
NCBI chr11:102,085,244...102,120,968
Ensembl chr11:102,085,258...102,120,992
G
Hes1
hes family bHLH transcription factor 1
ISO
mRNA:increased expression:kidney collecting duct (rat) protein:increased expression:kidney tubule (rat)
RGD
PMID:24397211 PMID:24325066
RGD:9685383 , RGD:9685389
NCBI chr16:29,883,259...29,886,614
Ensembl chr16:29,883,202...29,886,614
G
Hexb
hexosaminidase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22005293
NCBI chr13:97,312,839...97,334,865
Ensembl chr13:97,312,839...97,334,865
G
Hif1a
hypoxia inducible factor 1, alpha subunit
treatment
ISO
mRNA:increased expression:renal cortex (rat)
RGD
PMID:18593636 PMID:16762988 PMID:15673301
RGD:9068894 , RGD:10395386 , RGD:10395376
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Hipk1
homeodomain interacting protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36052886
NCBI chr 3:103,647,131...103,699,210
Ensembl chr 3:103,647,131...103,698,879
G
Hmgcr
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
IMP
associated with Sepsis
RGD
PMID:16557230
RGD:5508471
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
G
Hmox1
heme oxygenase 1
treatment
ISO
associated with Sepsis CTD Direct Evidence: therapeutic
CTD RGD
PMID:21048024 PMID:23807243
RGD:10755583
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hp
haptoglobin
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28885000 PMID:19270397
RGD:11041863
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
G
Hpx
hemopexin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 7:105,240,818...105,249,323
Ensembl chr 7:105,240,820...105,249,344
G
Hspa1a
heat shock protein 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12690470 PMID:19546256
NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
G
Hspa8
heat shock protein 8
ISO
protein:increased expression:kidney, lysosome (rat)
RGD
PMID:14966137
RGD:7242786
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
G
Icam1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:22659586
RGD:7175102
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7540432
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igf1r
insulin-like growth factor I receptor
ISO
mRNA: decreased expression: kidney: both cortex and medulla
RGD
PMID:9767523
RGD:7242908
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Igfbp1
insulin-like growth factor binding protein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7540432
NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546
G
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18460982
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il18
interleukin 18
IMP
RGD
PMID:11342578
RGD:6893450
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il1a
interleukin 1 alpha
IMP
RGD
PMID:21716595
RGD:6907069
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1b
interleukin 1 beta
ISO IEP IDA
mRNA:increased expression:kidney, liver, spleen (mouse) protein:increased expression:kidney (rat)
RGD
PMID:22750969 PMID:21677145 PMID:22286667 PMID:22659586
RGD:7175094 , RGD:7175314 , RGD:7175258 , RGD:7175102
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
ISO IDA
associated with Sepsis associated with Asphyxia; rat model treated with human protein
RGD
PMID:16763508 PMID:14610321 PMID:16259926
RGD:6907360 , RGD:6907375 , RGD:6907369
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il20
interleukin 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18496552
NCBI chr 1:130,834,722...130,839,033
Ensembl chr 1:130,834,722...130,839,188
G
Il6
interleukin 6
ISO
associated with Acute Lung Injury;protein:increased expression:plasma CTD Direct Evidence: therapeutic
CTD RGD
PMID:21570986 PMID:18074478
RGD:5128661
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Ins2
insulin II
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12243603
NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118
G
Jak2
Janus kinase 2
treatment
IEP
associated with Carcinoma, Lewis Lung, human cells in mouse model
RGD
PMID:31250048
RGD:149735351
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
G
Klk1
kallikrein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18227104
NCBI chr 7:43,874,784...43,879,046
Ensembl chr 7:43,874,784...43,879,042
G
Kng1
kininogen 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:513486 PMID:3015452
NCBI chr16:22,876,970...22,900,828
Ensembl chr16:22,876,615...22,900,828
G
Lcn2
lipocalin 2
ISO
protein:increased expression:urine associated with open cardiac surgeries;protein:increased expression:urine: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20623750 PMID:22005293 PMID:23052191 PMID:27888128 PMID:28885000 PMID:23683031 PMID:23336369 PMID:28411423 More...
RGD:7244370 , RGD:126781714 , RGD:125973912
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Lgals3
lectin, galactose binding, soluble 3
ISO
mRNA:increased expression:kidney
RGD
PMID:10980121
RGD:9685228
NCBI chr14:47,611,317...47,623,624
Ensembl chr14:47,605,208...47,623,617
G
Lrg1
leucine-rich alpha-2-glycoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34677723
NCBI chr17:56,426,678...56,428,946
Ensembl chr17:56,426,678...56,429,001
G
Lrp2
low density lipoprotein receptor-related protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29286200
NCBI chr 2:69,254,679...69,416,373
Ensembl chr 2:69,254,684...69,416,409
G
Mb
myoglobin
ISO
protein: increased expression: serum
RGD
PMID:23497406 PMID:9822635
RGD:7244253 , RGD:7244259
NCBI chr15:76,899,687...76,934,868
Ensembl chr15:76,899,687...76,934,870
G
Met
met proto-oncogene
ISO
protein:increased expression:renal parenchyma (rat)
RGD
PMID:17940345
RGD:2317469
NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979
G
Mfn1
mitofusin 1
ISO
protein:decreased expression:kidney (rat)
RGD
PMID:26480480
RGD:12910862
NCBI chr 3:32,583,594...32,633,384
Ensembl chr 3:32,583,614...32,633,388
G
Mir10a
microRNA 10a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30682439
NCBI chr11:96,207,991...96,208,100
Ensembl chr11:96,207,991...96,208,100
G
Mir122
microRNA 122
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30682439
NCBI chr18:65,381,932...65,381,997
Ensembl chr18:65,381,932...65,381,997
G
Mir140
microRNA 140
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30682439
NCBI chr 8:108,277,876...108,277,945
Ensembl chr 8:108,277,876...108,277,945
G
Mir143
microRNA 143
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30682439
NCBI chr18:61,782,267...61,782,329
Ensembl chr18:61,782,267...61,782,329
G
Mir146b
microRNA 146b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30682439
NCBI chr19:46,331,201...46,331,309
Ensembl chr19:46,331,201...46,331,309
G
Mir148a
microRNA 148a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30682439
NCBI chr 6:51,246,792...51,246,890
Ensembl chr 6:51,246,792...51,246,890
G
Mir151
microRNA 151
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30682439
NCBI chr15:73,126,664...73,126,731
Ensembl chr15:73,126,664...73,126,731
G
Mir152
microRNA 152
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32583487
NCBI chr11:96,741,219...96,741,291
Ensembl chr11:96,741,219...96,741,291
G
Mir192
microRNA 192
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30682439
NCBI chr19:6,314,874...6,314,962
Ensembl chr19:6,314,874...6,314,962
G
Mir215
microRNA 215
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30682439
NCBI chr 1:185,045,778...185,045,889
Ensembl chr 1:185,045,778...185,045,889
G
Mir23a
microRNA 23a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30682439
NCBI chr 8:84,935,147...84,935,221
Ensembl chr 8:84,935,147...84,935,221
G
Mir25
microRNA 25
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30682439
NCBI chr 5:138,163,583...138,163,666
Ensembl chr 5:138,163,583...138,163,666
G
Mir26a-1
microRNA 26a-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30682439
NCBI chr 9:118,860,864...118,860,953
Ensembl chr 9:118,860,864...118,860,953
G
Mir30a
microRNA 30a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30682439
NCBI chr 1:23,311,350...23,311,420
Ensembl chr 1:23,311,350...23,311,420
G
Mir30d
microRNA 30d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30682439
NCBI chr15:68,213,057...68,213,138
Ensembl chr15:68,213,057...68,213,138
G
Mir335
microRNA 335
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36052886
NCBI chr 6:30,741,298...30,741,395
Ensembl chr 6:30,741,298...30,741,395
G
Mir423
microRNA 423
disease_progression
ISO
miRNA:increased expression:serum, urine
RGD
PMID:32984995
RGD:158014895
NCBI chr11:76,968,890...76,968,998
Ensembl chr11:76,968,890...76,968,998
G
Mir486
microRNA 486
EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:30682439 PMID:35279909
NCBI chr 8:23,632,571...23,632,698
Ensembl chr 8:23,632,571...23,632,698
G
Mir494
microRNA 494
ISO
RNA:increased expression:urine
RGD
PMID:23160513
RGD:155883172
NCBI chr12:109,681,752...109,681,836
Ensembl chr12:109,681,752...109,681,836
G
Mir99a
microRNA 99a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30682439
NCBI chr16:77,395,824...77,395,888
Ensembl chr16:77,395,824...77,395,888
G
Mirlet7i
microRNA let7i
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30682439
NCBI chr10:122,821,545...122,821,629
Ensembl chr10:122,821,545...122,821,629
G
Mpo
myeloperoxidase
ISO
DNA:haplotye: : CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20623750 PMID:22739978 PMID:19793022
RGD:6909168 , RGD:6909185
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Mthfr
methylenetetrahydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17387702
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
G
Mtor
mechanistic target of rapamycin kinase
ISO
RGD
PMID:23022334
RGD:7245507
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Muc20
mucin 20
IEP
RGD
PMID:14565953
RGD:7364790
NCBI chr16:32,597,793...32,617,805
Ensembl chr16:32,597,793...32,617,805
G
Mug1
murinoglobulin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 6:121,815,455...121,866,016
Ensembl chr 6:121,815,500...121,866,016
G
Myc
myelocytomatosis oncogene
susceptibility
IEP
protein:decreased phosphorylation:kidney (mouse)
RGD
PMID:23228991
RGD:7207407
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
Ndufb8
NADH:ubiquinone oxidoreductase subunit B8
ISO
RGD
PMID:22160772
RGD:13801199
NCBI chr19:44,537,010...44,543,881
Ensembl chr19:44,537,011...44,543,879
G
Nes
nestin
ISO
RGD
PMID:24503548
RGD:11570523
NCBI chr 3:87,878,400...87,887,758
Ensembl chr 3:87,878,385...87,887,758
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24958931 PMID:24291173
RGD:10412697
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfkb1
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29286200
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
G
Nos1
nitric oxide synthase 1, neuronal
ISO
RGD
PMID:14531809
RGD:13825139
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
G
Nos2
nitric oxide synthase 2, inducible
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9810145
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nos3
nitric oxide synthase 3, endothelial cell
ISO
CTD Direct Evidence: marker/mechanism in females;mRNA:increased expression:cortex of kidney (rat)
CTD RGD
PMID:9788586 PMID:28947737
RGD:13450947
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Nppa
natriuretic peptide type A
ISO
mRNA:increased expression:kidney CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:1825077 PMID:2948068 PMID:19298916 PMID:22209992
RGD:7247715
NCBI chr 4:148,085,179...148,086,531
Ensembl chr 4:148,085,179...148,086,536
G
Nppb
natriuretic peptide type B
ISO
associated with lung diseases;protein:increased expression:serum: mRNA:increased expression:kidney associated with Myocardial Infarction;protein:increased expression:serum: associated with Pneumonia;protein:increased expression:serum:
RGD
PMID:23837838 PMID:22209992 PMID:23192919 PMID:23415693
RGD:7247620 , RGD:7247715 , RGD:7247624 , RGD:7247622
NCBI chr 4:148,070,264...148,071,662
Ensembl chr 4:148,070,245...148,071,662
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:26723870 PMID:28230744
RGD:13440091
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Ocln
occludin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19766176
NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226
G
Orm1
orosomucoid 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 4:63,262,793...63,266,400
Ensembl chr 4:63,262,797...63,266,400
G
Parp1
poly (ADP-ribose) polymerase family, member 1
IMP
RGD
PMID:21884784
RGD:5510015
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pkd2
polycystin 2, transient receptor potential cation channel
ISO
protein:altered localization
RGD
PMID:12089381
RGD:7175293
NCBI chr 5:104,599,379...104,653,685
Ensembl chr 5:104,607,316...104,653,685
G
Plat
plasminogen activator, tissue
ISO
protein:increased expression:plasma (human)
RGD
PMID:9767551
RGD:11541071
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Plg
plasminogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr17:12,597,496...12,638,271
Ensembl chr17:12,597,495...12,638,272
G
Pomc
pro-opiomelanocortin-alpha
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17216604
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
G
Pparg
peroxisome proliferator activated receptor gamma
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:20623750 PMID:24011919 PMID:24433871 PMID:17494862
RGD:8553020
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Ppargc1a
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha
IEP IMP
associated with Endotoxemia; mRNA:decreased expression:kidney (mouse)
RGD
PMID:21881206 PMID:21881206
RGD:7242026 , RGD:7242026
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
G
Proc
protein C
treatment
ISO
RGD
PMID:19092124
RGD:11250410
NCBI chr18:32,256,179...32,272,623
Ensembl chr18:32,256,179...32,272,623
G
Procr
protein C receptor, endothelial
treatment
ISO
associated with Sepsis
RGD
PMID:23807243
RGD:10755583
NCBI chr 2:155,592,159...155,597,391
Ensembl chr 2:155,593,037...155,597,391
G
Ptafr
platelet-activating factor receptor
treatment
ISO
associated with Endotoxemia
RGD
PMID:2538527
RGD:10043182
NCBI chr 4:132,291,378...132,309,994
Ensembl chr 4:132,291,378...132,309,994
G
Ptger4
prostaglandin E receptor 4 (subtype EP4)
treatment
ISO
RGD
PMID:16871242
RGD:10003092
NCBI chr15:5,262,880...5,273,668
Ensembl chr15:5,236,142...5,273,668
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:21893983
RGD:5508181
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Rapgef3
Rap guanine nucleotide exchange factor (GEF) 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21745194
NCBI chr15:97,637,886...97,666,300
Ensembl chr15:97,642,651...97,665,853
G
Rb1
RB transcriptional corepressor 1
ISO
associated with Sepsis;protein:increased phosphorylation:kidney
RGD
PMID:19428114
RGD:8547990
NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
G
Ren1
renin 1 structural
exacerbates
ISO
Associated with toxic shock syndrome;protein:increased expression:blood plasma (human)
RGD
PMID:30407370
RGD:125097506
NCBI chr 1:133,278,412...133,288,058
Ensembl chr 1:133,278,248...133,288,063
G
Scgb1a1
secretoglobin, family 1A, member 1
ISO
associated with LPS induced endotoxemia
RGD
PMID:18824919
RGD:2313129
NCBI chr19:9,061,006...9,065,320
Ensembl chr19:9,061,000...9,065,322
G
Serpinc1
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1
ISO
associated with heart failure; protein:decreased activity:plasma:
RGD
PMID:26108065
RGD:11354006
NCBI chr 1:160,806,153...160,830,113
Ensembl chr 1:160,806,155...160,833,433
G
Sirt1
sirtuin 1
severity
ISO
protein:increased expression:kidney (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21416250 PMID:21416250
RGD:10047111
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
G
Slc11a1
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 1:74,414,318...74,429,974
Ensembl chr 1:74,414,354...74,425,221
G
Slc22a1
solute carrier family 22 (organic cation transporter), member 1
treatment
ISO
RGD
PMID:22414646
RGD:7243179
NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
G
Slc22a12
solute carrier family 22 (organic anion/cation transporter), member 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14655203
NCBI chr19:6,585,884...6,593,100
Ensembl chr19:6,585,875...6,593,062
G
Slc22a2
solute carrier family 22 (organic cation transporter), member 2
treatment susceptibility
ISO
DNA:SNP: :808G>T (rs316019) human mRNA:decreased expression:kidney
RGD
PMID:22414646 PMID:19625999 PMID:18612803
RGD:7243179 , RGD:7243884 , RGD:7243880
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
G
Slc34a1
solute carrier family 34 (sodium phosphate), member 1
disease_progression
IEP
associated with Sepsis; protein:decreased expression:renal proximal tubule (mouse)
RGD
PMID:19729856
RGD:7242943
NCBI chr13:55,547,435...55,562,508
Ensembl chr13:55,546,000...55,563,405
G
Sod1
superoxide dismutase 1, soluble
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Spp1
secreted phosphoprotein 1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11274264 PMID:20623750 PMID:22863853
RGD:6903264
NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
G
Tbx1
T-box 1
ISO
mRNA:increased expression:kidney (rat)
RGD
PMID:24817956
RGD:155882498
NCBI chr16:18,399,729...18,409,412
Ensembl chr16:18,399,729...18,409,421
G
Tff3
trefoil factor 3, intestinal
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23052191
NCBI chr17:31,344,280...31,348,585
Ensembl chr17:31,344,280...31,348,620
G
Tgfa
transforming growth factor alpha
ISO
mRNA:increased expression:kidney
RGD
PMID:11340354
RGD:10395241
NCBI chr 6:86,172,020...86,252,726
Ensembl chr 6:86,172,205...86,252,701
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10469268
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tgfbr1
transforming growth factor, beta receptor I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34677723
NCBI chr 4:47,353,258...47,414,926
Ensembl chr 4:47,353,222...47,414,931
G
Thbd
thrombomodulin
treatment
ISO
RGD
PMID:19176699 PMID:17804460
RGD:5684994 , RGD:5685010
NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
G
Tlr2
toll-like receptor 2
IMP ISO
associated with Sepsis CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29286200 PMID:22655058
RGD:7207898
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr4
toll-like receptor 4
treatment
IMP ISO IEP
associated with Sepsis CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29286200 PMID:22655058 PMID:16638912 PMID:22266601
RGD:7207898 , RGD:7241084 , RGD:6892690
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tlr9
toll-like receptor 9
IMP
associated with Sepsis
RGD
PMID:23548820
RGD:7245966
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
G
Tnf
tumor necrosis factor
susceptibility
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16595132 PMID:18460982 PMID:20623750 PMID:21150875
RGD:7245548
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf12a
tumor necrosis factor receptor superfamily, member 12a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23052191
NCBI chr17:23,894,419...23,896,423
Ensembl chr17:23,894,419...23,896,442
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
susceptibility
ISO IMP
associated with Acute Lung Injury associated with Endotoxemia associated with Shock, Septic;protein:increased expression:serum
RGD
PMID:18074478 PMID:21150875 PMID:12023385 PMID:12500222
RGD:5128661 , RGD:7245548 , RGD:7245535 , RGD:7245534
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Tnfrsf1b
tumor necrosis factor receptor superfamily, member 1b
ISO IMP
associated with Acute Lung Injury associated with Shock, Septic;protein:increased expression:serum
RGD
PMID:18074478 PMID:12500222 PMID:12865254
RGD:5128661 , RGD:7245534 , RGD:7245532
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
G
Trf
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643
G
Trp53
transformation related protein 53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20603111
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Ttr
transthyretin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28885000
NCBI chr18:20,797,266...20,807,383
Ensembl chr18:20,798,337...20,807,378
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3864191
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Ugt1a9
UDP glucuronosyltransferase 1 family, polypeptide A9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 1:87,998,501...88,147,724
Ensembl chr 1:87,998,522...88,146,719
G
Uox
urate oxidase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16313266
NCBI chr 3:146,302,904...146,337,238
Ensembl chr 3:146,276,181...146,338,060
G
Uts2r
urotensin 2 receptor
ISO
RGD
PMID:15146030
RGD:2306847
NCBI chr11:121,051,097...121,052,799
Ensembl chr11:121,051,097...121,052,799
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:20943766 PMID:22808199
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Wnt4
wingless-type MMTV integration site family, member 4
ISO
RGD
PMID:12707392
RGD:727218
NCBI chr 4:137,004,946...137,026,812
Ensembl chr 4:137,004,800...137,027,037
G
Xdh
xanthine dehydrogenase
treatment
ISO IDA
associated with Reperfusion Injury
RGD
PMID:22571266 PMID:18539378 PMID:19628223
RGD:7247641 , RGD:7247656 , RGD:7247650
NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
G
Zfp644
zinc finger protein 644
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36052886
NCBI chr 5:106,764,605...106,844,696
Ensembl chr 5:106,764,605...106,845,153
G
Ak4
adenylate kinase 4
ISO
protein:decreased expression:kidney (rat)
RGD
PMID:21152904
RGD:5134352
NCBI chr 4:101,273,675...101,324,968
Ensembl chr 4:101,276,474...101,324,192
G
Bmp7
bone morphogenetic protein 7
ISO
associated with Kidney Reperfusion Injury;protein:increased expression:kidney
RGD
PMID:16284088
RGD:1601494
NCBI chr 2:172,709,805...172,782,114
Ensembl chr 2:172,709,805...172,782,114
G
Cct7
chaperonin containing TCP1 subunit 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31825490
NCBI chr 6:85,428,487...85,445,459
Ensembl chr 6:85,428,496...85,445,457
G
Ciita
class II transactivator
IEP
mRNA:increased expression:kidney
RGD
PMID:9422398
RGD:7242901
NCBI chr16:10,297,877...10,348,928
Ensembl chr16:10,297,923...10,346,282
G
Fabp1
fatty acid binding protein 1, liver
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18368030
NCBI chr 6:71,176,863...71,182,018
Ensembl chr 6:71,176,811...71,182,007
G
Gsr
glutathione reductase
IMP ISO
protein:decreased activity:renal cortex:
RGD
PMID:17078987 PMID:12885594
RGD:7257555 , RGD:7257573
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Havcr1
hepatitis A virus cellular receptor 1
ISO
protein:increased expression:kidney tubule, urine:
RGD
PMID:12081583
RGD:7245970
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
G
Nog
noggin
ISO
associated with Kidney Reperfusion Injury
RGD
PMID:16284088
RGD:1601494
NCBI chr11:89,191,464...89,193,385
Ensembl chr11:89,191,464...89,193,158
G
Pomc
pro-opiomelanocortin-alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:4358912 PMID:6254450
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19834340
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
G
Sod2
superoxide dismutase 2, mitochondrial
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19917352
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Tek
TEK receptor tyrosine kinase
ISO
associated with Kidney Reperfusion Injury
RGD
PMID:16284088
RGD:1601494
NCBI chr 4:94,627,322...94,763,213
Ensembl chr 4:94,627,526...94,763,213
G
Aco1
aconitase 1
ISO
RGD
PMID:20176611
RGD:11541086
NCBI chr 4:40,143,429...40,199,011
Ensembl chr 4:40,143,081...40,198,338
G
Alb
albumin
disease_progression
ISO
RGD
PMID:24370342
RGD:11035281
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Ccl3
C-C motif chemokine ligand 3
ISO
RGD
PMID:17298994
RGD:7241819
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
G
Ccn2
cellular communication network factor 2
disease_progression
ISO
mRNA, protein:increased expression:kidney (rat)
RGD
PMID:19921985
RGD:150517553
NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
G
Clu
clusterin
treatment
ISO
RGD
PMID:22494435
RGD:9068431
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
G
Cs
citrate synthase
treatment
ISO
RGD
PMID:20005400
RGD:243048470
NCBI chr10:128,173,596...128,198,351
Ensembl chr10:128,173,603...128,198,348
G
Mmp3
matrix metallopeptidase 3
ISO
RGD
PMID:22845765
RGD:7241226
NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
G
Mmp7
matrix metallopeptidase 7
treatment
ISO
RGD
PMID:18209025
RGD:9685339
NCBI chr 9:7,692,095...7,699,587
Ensembl chr 9:7,692,091...7,699,586
G
Pdgfa
platelet derived growth factor, alpha
ISO
RGD
PMID:11889420
RGD:11080974
NCBI chr 5:138,961,761...138,986,336
Ensembl chr 5:138,961,769...138,983,125
G
Pdgfb
platelet derived growth factor, B polypeptide
ISO
mRNA:increased expression:kidney:
RGD
PMID:15785371 PMID:11889420
RGD:10449491 , RGD:11080974
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
G
Pdgfra
platelet derived growth factor receptor, alpha polypeptide
ISO
RGD
PMID:11889420
RGD:11080974
NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876
G
Pdgfrb
platelet derived growth factor receptor, beta polypeptide
ISO
RGD
PMID:11889420
RGD:11080974
NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
G
Plau
plasminogen activator, urokinase
ISO
protein:increased secretion:T lymphocyte (human)
RGD
PMID:16387096
RGD:7241259
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Pparg
peroxisome proliferator activated receptor gamma
ISO
protein:increased expression:kidney:
RGD
PMID:16221712
RGD:13208600
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
treatment
ISO
protein:increased expression:kidney:
RGD
PMID:16221712 PMID:18192922
RGD:13208600 , RGD:13208601
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Casp12
caspase 12
treatment
ISO
RGD
PMID:27781957
RGD:13782262
NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032
G
Casp3
caspase 3
treatment
ISO
RGD
PMID:27781957
RGD:13782262
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Crp
C-reactive protein, pentraxin-related
ISO
associated with coronary disease;
RGD
PMID:23102387
RGD:6909166
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Ddit3
DNA-damage inducible transcript 3
treatment
ISO
RGD
PMID:27781957
RGD:13782262
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
G
Ece1
endothelin converting enzyme 1
ISO
mRNA,protein:increased expression:kidney medulla
RGD
PMID:18385664
RGD:7243946
NCBI chr 4:137,589,548...137,692,540
Ensembl chr 4:137,589,548...137,692,540
G
Havcr1
hepatitis A virus cellular receptor 1
ISO
protein:increased expression:urine:
RGD
PMID:23335628
RGD:7245471
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
G
Hspa5
heat shock protein 5
treatment
ISO
RGD
PMID:27781957
RGD:13782262
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
G
Il1b
interleukin 1 beta
ISO
associated with Diabetes Mellitus, Experimental
RGD
PMID:22094062
RGD:7175334
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Lcn2
lipocalin 2
ISO
protein:increased expression:urine: associated with Diabetes Mellitus, Experimental; protein:increased expression:urine
RGD
PMID:23335628 PMID:23085980
RGD:7245471 , RGD:7245484
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Mapk8
mitogen-activated protein kinase 8
treatment
ISO
RGD
PMID:27781957
RGD:13782262
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mir188
microRNA 188
ISO
RNA:increased expression:plasma RNA:increased expression:plasma, kidney
RGD
PMID:27528406 PMID:27528406
RGD:35673289 , RGD:35673289
NCBI chr X:7,114,228...7,114,295
Ensembl chr X:7,114,228...7,114,295
G
Mir30a
microRNA 30a
ISO
RNA:increased expression:plasma
RGD
PMID:27528406 PMID:27528406
RGD:35673289 , RGD:35673289
NCBI chr 1:23,311,350...23,311,420
Ensembl chr 1:23,311,350...23,311,420
G
Mir30e
microRNA 30e
ISO
RNA:increased expression:plasma
RGD
PMID:27528406 PMID:27528406
RGD:35673289 , RGD:35673289
NCBI chr 4:120,629,803...120,629,894
Ensembl chr 4:120,629,803...120,629,894
G
Mpo
myeloperoxidase
ISO
RGD
PMID:20722568
RGD:6909183
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Nppa
natriuretic peptide type A
ISO
RGD
PMID:19298916
RGD:7247719
NCBI chr 4:148,085,179...148,086,531
Ensembl chr 4:148,085,179...148,086,536
G
Nppb
natriuretic peptide type B
ISO
associated with Heart Failure
RGD
PMID:20438292
RGD:7248591
NCBI chr 4:148,070,264...148,071,662
Ensembl chr 4:148,070,245...148,071,662
G
Edn1
endothelin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7967349
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Hmox1
heme oxygenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21253390
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Sod1
superoxide dismutase 1, soluble
IDA
RGD
PMID:15531919
RGD:1581228
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Tlr4
toll-like receptor 4
ISO
mRNA, protein:increased expression:kidney
RGD
PMID:18093430
RGD:4144102
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:plasma
RGD
PMID:18093430
RGD:4144102
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Ace
angiotensin I converting enzyme
ISO
RGD
PMID:21680852
RGD:6893484
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Ace2
angiotensin converting enzyme 2
ISO
mRNA:decreased expression:kidney
RGD
PMID:20528771
RGD:9685432
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
G
Acta1
actin alpha 1, skeletal muscle
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr 8:124,618,497...124,621,514
Ensembl chr 8:124,618,508...124,621,490
G
Acvr2b
activin receptor IIB
treatment
ISO
human construct in rat model
RGD
PMID:27732750
RGD:329322881
NCBI chr 9:119,231,081...119,271,214
Ensembl chr 9:119,231,184...119,264,061
G
Adam17
a disintegrin and metallopeptidase domain 17
treatment
ISO
RGD
PMID:22015440
RGD:13703100
NCBI chr12:21,373,510...21,423,633
Ensembl chr12:21,373,510...21,423,633
G
Adam2
a disintegrin and metallopeptidase domain 2
ISO
RGD
PMID:11967014
RGD:10047130
NCBI chr14:66,264,778...66,315,300
Ensembl chr14:66,264,778...66,315,182
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
RGD
PMID:18272597
RGD:9684850
NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001
G
Adipoq
adiponectin, C1Q and collagen domain containing
treatment
ISO
RGD
PMID:21412771
RGD:8695946
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adm
adrenomedullin
treatment
ISO
protein:increased expression:serum:
RGD
PMID:20538296 PMID:20538296
RGD:7364948 , RGD:7364948
NCBI chr 7:110,226,864...110,229,027
Ensembl chr 7:110,226,868...110,229,027
G
Akr1a1
aldo-keto reductase family 1, member A1
IMP
RGD
PMID:31089212
RGD:27226686
NCBI chr 4:116,493,707...116,508,871
Ensembl chr 4:116,493,707...116,508,877
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
IMP
RGD
PMID:22022451
RGD:7241603
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Anxa1
annexin A1
treatment
ISO
RGD
PMID:20953576
RGD:7421585
NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308
G
Anxa5
annexin A5
ISO
RGD
PMID:21918686
RGD:7242028
NCBI chr 3:36,503,072...36,530,036
Ensembl chr 3:36,503,072...36,530,043
G
Apaf1
apoptotic peptidase activating factor 1
treatment
ISO
RGD
PMID:26362957
RGD:13703110
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
G
Apoa1
apolipoprotein A-I
treatment
ISO
RGD
PMID:18535924
RGD:7241574
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
G
Atm
ataxia telangiectasia mutated
ISO
protein:increased expression:kidney
RGD
PMID:22768306
RGD:10053607
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
G
Bax
BCL2-associated X protein
treatment
ISO
RGD
PMID:23151253
RGD:10054101
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
treatment
ISO
RGD
PMID:18221257 PMID:29285062
RGD:2293026 , RGD:13792599
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bdkrb1
bradykinin receptor, beta 1
IMP
RGD
PMID:18725957
RGD:7241559
NCBI chr12:105,570,350...105,571,770
Ensembl chr12:105,569,344...105,571,687
G
Becn1
beclin 1, autophagy related
treatment
ISO
RGD
PMID:26412257
RGD:11561958
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
G
Bmi1
Bmi1 polycomb ring finger oncogene
IEP
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 2:18,681,953...18,691,440
Ensembl chr 2:18,681,829...18,691,440
G
Bnip3
BCL2/adenovirus E1B interacting protein 3
ISO
mRNA, protein:increased expression:kidney
RGD
PMID:23698117
RGD:11561968
NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
G
C3
complement component 3
treatment
ISO
RGD
PMID:19691975
RGD:7411689
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Calca
calcitonin/calcitonin-related polypeptide, alpha
ISO
RGD
PMID:19194162
RGD:7204479
NCBI chr 7:114,225,223...114,236,145
Ensembl chr 7:114,230,713...114,235,592
G
Casp3
caspase 3
treatment
ISO
RGD
PMID:23151253
RGD:10054101
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp7
caspase 7
ISO
RGD
PMID:17596683
RGD:5684536
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
G
Ccl11
C-C motif chemokine ligand 11
treatment
IDA
RGD
PMID:22160777
RGD:7247742
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
G
Ccl2
C-C motif chemokine ligand 2
treatment ameliorates
IEP ISO
mRNA, protein:increased expression:kidney, lung, serum
RGD
PMID:20396927 PMID:18650485 PMID:24920753
RGD:4891433 , RGD:11526113 , RGD:329845564
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccn1
cellular communication network factor 1
ameliorates
IMP
RGD
PMID:24920753
RGD:329845564
NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736
G
Cd14
CD14 antigen
IEP
mRNA,protein:increased expression:kidney
RGD
PMID:10966493
RGD:7204444
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
G
Cd40
CD40 antigen
treatment
ISO
RGD
PMID:25993320
RGD:11251055
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cfb
complement factor B
IMP
RGD
PMID:16467447 PMID:12538716
RGD:7242709 , RGD:7242734
NCBI chr17:35,075,350...35,081,492
Ensembl chr17:35,075,350...35,081,494
G
Cfh
complement component factor h
treatment
ISO
protein:decreased expression:serum:
RGD
PMID:20538296 PMID:20538296
RGD:7364948 , RGD:7364948
NCBI chr 1:140,013,593...140,111,149
Ensembl chr 1:140,012,446...140,111,502
G
Ciita
class II transactivator
IEP
RGD
PMID:14569092
RGD:7242896
NCBI chr16:10,297,877...10,348,928
Ensembl chr16:10,297,923...10,346,282
G
Cited1
Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1
IEP
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr X:101,290,984...101,295,787
Ensembl chr X:101,290,987...101,295,787
G
Col1a1
collagen, type I, alpha 1
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
Col3a1
collagen, type III, alpha 1
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
G
Csf1
colony stimulating factor 1 (macrophage)
IMP ISO
mRNA:increased expression:kidney
RGD
PMID:23143303 PMID:19196448
RGD:7257565 , RGD:7257570
NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
G
Csf1r
colony stimulating factor 1 receptor
IMP
RGD
PMID:23143303
RGD:7257565
NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
IMP ISO
RGD
PMID:22189844 PMID:9407517
RGD:7204675 , RGD:7204727
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
G
Cxcl2
C-X-C motif chemokine ligand 2
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Cxcr2
C-X-C motif chemokine receptor 2
IMP
RGD
PMID:20038794
RGD:7257679
NCBI chr 1:74,193,153...74,200,405
Ensembl chr 1:74,193,150...74,200,405
G
Cxcr4
C-X-C motif chemokine receptor 4
ISO
protein:increased expression:kidney
RGD
PMID:29073721
RGD:13825150
NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
treatment
ISO
RGD
PMID:23552495
RGD:7244372
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
G
Daxx
Fas death domain-associated protein
IEP ISO
protein:increased expression:kidney:
RGD
PMID:18480747 PMID:18480747
RGD:9587836 , RGD:9587836
NCBI chr17:34,128,379...34,134,564
Ensembl chr17:34,128,388...34,134,564
G
Ddr1
discoidin domain receptor family, member 1
IEP
protein:increased expression:kidney (mouse)
RGD
PMID:31383731
RGD:151347540
NCBI chr17:35,992,459...36,015,633
Ensembl chr17:35,992,459...36,015,513
G
Dhfr
dihydrofolate reductase
treatment
ISO
mRNA,protein:decreased expression:kidney:
RGD
PMID:18408363
RGD:11040540
NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561
G
Drd3
dopamine receptor D3
treatment
ISO
RGD
PMID:25989500
RGD:13506961
NCBI chr16:43,574,285...43,646,353
Ensembl chr16:43,574,389...43,643,295
G
Eed
embryonic ectoderm development
IEP
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 7:89,603,862...89,630,184
Ensembl chr 7:89,603,862...89,630,191
G
Egln1
egl-9 family hypoxia-inducible factor 1
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:19349364
RGD:11252083
NCBI chr 8:125,635,325...125,676,063
Ensembl chr 8:125,635,326...125,676,063
G
Egln3
egl-9 family hypoxia-inducible factor 3
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:19349364
RGD:11252083
NCBI chr12:54,225,767...54,250,660
Ensembl chr12:54,225,767...54,250,646
G
Elane
elastase, neutrophil expressed
treatment
ISO
RGD
PMID:16980042
RGD:10450580
NCBI chr10:79,722,146...79,724,050
Ensembl chr10:79,722,081...79,724,049
G
Eng
endoglin
ISO IMP
mRNA, protein:increased expression:kidney (rat)
RGD
PMID:16751653 PMID:16751653
RGD:7248779 , RGD:7248779
NCBI chr 2:32,536,607...32,572,681
Ensembl chr 2:32,536,607...32,572,681
G
Ep300
E1A binding protein p300
ISO
protein:altered localization:kidney (rat)
RGD
PMID:23936185
RGD:7257563
NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:19961832 PMID:25581532
RGD:10401077 , RGD:11041698
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
IEP
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275
G
F3
coagulation factor III
ISO
protein:decreased expression:lung
RGD
PMID:25883098
RGD:11341735
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
G
Fas
Fas cell surface death receptor
treatment
ISO
RGD
PMID:29285062
RGD:13792599
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fasl
Fas ligand
treatment
ISO
RGD
PMID:29285062
RGD:13792599
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
G
Fcgr1
Fc receptor, IgG, high affinity I
treatment
ISO
RGD
PMID:22402584
RGD:9685699
NCBI chr 3:96,190,225...96,201,285
Ensembl chr 3:96,190,225...96,201,285
G
Fga
fibrinogen alpha chain
ISO
mRNA,protein:increased expression:kidney
RGD
PMID:21685370
RGD:7175292
NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
G
Fgb
fibrinogen beta chain
treatment
ISO
mRNA, protein:increased expression:kidney
RGD
PMID:21685370 PMID:21685370
RGD:7175292 , RGD:7175292
NCBI chr 3:82,949,553...82,957,170
Ensembl chr 3:82,947,448...82,957,170
G
Fgfr2
fibroblast growth factor receptor 2
exacerbates ameliorates
IEP IMP ISO
protein:increased phosphorylation:kidney (mouse)
RGD
PMID:20591940 PMID:32523960 PMID:29344510 PMID:22688984
RGD:155663667 , RGD:155782882 , RGD:155782904 , RGD:155882537
NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079
G
Fgg
fibrinogen gamma chain
ISO
mRNA,protein:increased expression:kidney
RGD
PMID:21685370
RGD:7175292
NCBI chr 3:82,915,031...82,922,363
Ensembl chr 3:82,915,031...82,922,356
G
Fn1
fibronectin 1
ISO
RGD
PMID:11352844
RGD:7205629
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
G
Fos
FBJ osteosarcoma oncogene
IEP
RGD
PMID:19095962
RGD:7242184
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Gfer
growth factor, augmenter of liver regeneration
treatment
ISO
protein:increased expression:kidney:
RGD
PMID:20332418 PMID:20332418
RGD:9685723 , RGD:9685723
NCBI chr17:24,912,164...24,915,065
Ensembl chr17:24,912,161...24,915,130
G
Glo1
glyoxalase 1
ISO
RGD
PMID:19211689 PMID:19211689
RGD:7242566 , RGD:7242566
NCBI chr17:30,811,835...30,831,633
Ensembl chr17:30,803,910...30,845,845
G
Gpx3
glutathione peroxidase 3
ISO
protein:decreased expression:kidney mRNA:decreased expression:kidney
RGD
PMID:37033969 PMID:22442209
RGD:401827821 , RGD:401827906
NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
G
Gsr
glutathione reductase
treatment
ISO
RGD
PMID:24630969
RGD:10401866
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Gstm1
glutathione S-transferase, mu 1
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:29137244
RGD:158014894
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstt1
glutathione S-transferase, theta 1
ISO
protein:decreased expression:kidney
RGD
PMID:37033969
RGD:401827821
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
H2ax
H2A.X variant histone
treatment
ISO
RGD
PMID:23726287
RGD:8693706
NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
G
Has1
hyaluronan synthase 1
ISO
RGD
PMID:22529164
RGD:9588636
NCBI chr17:18,063,588...18,075,450
Ensembl chr17:18,063,585...18,075,467
G
Has2
hyaluronan synthase 2
ISO
RGD
PMID:22529164
RGD:9588636
NCBI chr15:56,529,023...56,557,942
Ensembl chr15:56,529,023...56,557,935
G
Havcr1
hepatitis A virus cellular receptor 1
ISO IEP
protein:increased expression:urine:
RGD
PMID:23552495 PMID:23085062 PMID:23019274
RGD:7244372 , RGD:7245489 , RGD:7245495
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
G
Hif1a
hypoxia inducible factor 1, alpha subunit
treatment severity
ISO
RGD
PMID:17519789 PMID:22432008
RGD:1626334 , RGD:9068883
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Hmox1
heme oxygenase 1
treatment
ISO
RGD
PMID:21291499
RGD:10755580
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hsf1
heat shock factor 1
ISO
protein:increased expression:kidney (rat)
RGD
PMID:23102208
RGD:10402775
NCBI chr15:76,361,562...76,385,355
Ensembl chr15:76,361,622...76,386,113
G
Hspa8
heat shock protein 8
ISO
RGD
PMID:7569112
RGD:7242788
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
G
Hyal1
hyaluronoglucosaminidase 1
ISO
RGD
PMID:22529164
RGD:9588636
NCBI chr 9:107,454,149...107,458,898
Ensembl chr 9:107,454,126...107,458,909
G
Hyal2
hyaluronoglucosaminidase 2
ISO
RGD
PMID:22529164
RGD:9588636
NCBI chr 9:107,445,096...107,449,975
Ensembl chr 9:107,445,144...107,449,978
G
Ifng
interferon gamma
treatment
IEP
RGD
PMID:28355607
RGD:14975115
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Igf1r
insulin-like growth factor I receptor
ISO
mRNA: increased expression: kidney: 3 and 5 days post ischemia
RGD
PMID:10990448
RGD:7242905
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Ikbkb
inhibitor of kappaB kinase beta
treatment
ISO
RGD
PMID:19546526
RGD:7495779
NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605
G
Il10
interleukin 10
treatment
ISO IEP
RGD
PMID:24079335 PMID:28664613
RGD:7364864 , RGD:14975137
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il12b
interleukin 12b
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
G
Il18
interleukin 18
treatment
ISO
RGD
PMID:22089199
RGD:8655971
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il1b
interleukin 1 beta
ameliorates
ISO IEP
RGD
PMID:20030532 PMID:24920753
RGD:7175501 , RGD:329845564
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
ISO IMP
rat model treated with human protein mouse model treated with human protein
RGD
PMID:18363573 PMID:16849996 PMID:9555664
RGD:6907101 , RGD:6907359 , RGD:6909149
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il6
interleukin 6
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Inhbb
inhibin beta-B
ISO
protein:increased expression:serum (rat)
RGD
PMID:27732750
RGD:329322881
NCBI chr 1:119,343,193...119,349,978
Ensembl chr 1:119,343,195...119,349,978
G
Itgb2
integrin beta 2
ISO
Associated with renal transplant patients
RGD
PMID:20504838 PMID:11007822
RGD:6907049 , RGD:6907073
NCBI chr10:77,366,164...77,401,542
Ensembl chr10:77,366,086...77,401,542
G
Kcnj11
potassium inwardly rectifying channel, subfamily J, member 11
ISO
protein:decreased expression:kidney
RGD
PMID:21250976
RGD:7297045
NCBI chr 7:45,746,545...45,750,215
Ensembl chr 7:45,743,377...45,750,188
G
Kl
klotho
treatment
ISO IMP
mRNA,protein:decreased expression:renal tubule:
RGD
PMID:16204278 PMID:16204278
RGD:10403064 , RGD:10403064
NCBI chr 5:150,876,072...150,917,282
Ensembl chr 5:150,876,072...150,917,282
G
Kmt2a
lysine (K)-specific methyltransferase 2A
IEP
protein:increased expression:kidney (mouse)
RGD
PMID:31570196
RGD:155888490
NCBI chr 9:44,714,652...44,793,492
Ensembl chr 9:44,714,652...44,792,594
G
Lcn2
lipocalin 2
ISO IEP
protein:increased expression:urine: mRNA,protein:increased expression:kidney: mRNA,protein:increased expression:kidney,urine
RGD
PMID:23364806 PMID:23085062 PMID:20181666 PMID:27800610
RGD:7245469 , RGD:7245489 , RGD:126779563 , RGD:126790572
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Lep
leptin
resistance
ISO
RGD
PMID:22969992
RGD:6909133
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Lgals3
lectin, galactose binding, soluble 3
ISO
mRNA:increased expression:kidney
RGD
PMID:10980121
RGD:9685228
NCBI chr14:47,611,317...47,623,624
Ensembl chr14:47,605,208...47,623,617
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
IEP ISO
RGD
PMID:20075199 PMID:26412257
RGD:11561916 , RGD:11561958
NCBI chr 2:155,118,284...155,119,993
Ensembl chr 2:155,118,217...155,119,993
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
treatment
ISO
RGD
PMID:23952292
RGD:10412647
NCBI chr10:19,809,847...20,018,496
Ensembl chr10:19,810,218...20,018,499
G
Mc1r
melanocortin 1 receptor
ISO
protein:decreased expression:kidney outer medulla
RGD
PMID:18790174
RGD:5687322
NCBI chr 8:124,133,839...124,137,483
Ensembl chr 8:124,133,846...124,137,483
G
Mir146
microRNA 146
treatment
ISO
RGD
PMID:27760486
RGD:155882556
NCBI chr11:43,265,224...43,265,288
Ensembl chr11:43,265,224...43,265,288
G
Mir320
microRNA 320
treatment
ISO
RGD
PMID:31089916 PMID:27760486
RGD:155882543 , RGD:155882556
NCBI chr14:70,680,950...70,681,031
Ensembl chr14:70,680,950...70,681,031
G
Mir381
microRNA 381
ISO
RNA:decreased expression:kidney
RGD
PMID:29073721
RGD:13825150
NCBI chr12:109,693,256...109,693,330
Ensembl chr12:109,693,256...109,693,330
G
Mir423
microRNA 423
treatment
ISO
RGD
PMID:29137244
RGD:158014894
NCBI chr11:76,968,890...76,968,998
Ensembl chr11:76,968,890...76,968,998
G
Mir494
microRNA 494
ameliorates
IMP
RGD
PMID:23160513
RGD:155883172
NCBI chr12:109,681,752...109,681,836
Ensembl chr12:109,681,752...109,681,836
G
Mpo
myeloperoxidase
ISO IMP
protein:increased activity:kidney
RGD
PMID:22950848 PMID:18055546
RGD:6909167 , RGD:7174699
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Muc1
mucin 1, transmembrane
treatment
ISO
RGD
PMID:22019164
RGD:7245959
NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688
G
Myc
myelocytomatosis oncogene
ISO
mRNA:increased expression:kidney (rat)
RGD
PMID:17220792
RGD:7207777
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
Ndufb8
NADH:ubiquinone oxidoreductase subunit B8
ISO IEP
RGD
PMID:24096033 PMID:22160772
RGD:13801197 , RGD:13801199
NCBI chr19:44,537,010...44,543,881
Ensembl chr19:44,537,011...44,543,879
G
Nes
nestin
ISO
RGD
PMID:24503548
RGD:11570523
NCBI chr 3:87,878,400...87,887,758
Ensembl chr 3:87,878,385...87,887,758
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
treatment
ISO
RGD
PMID:31089916
RGD:155882543
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nos2
nitric oxide synthase 2, inducible
treatment
ISO
RGD
PMID:18408363
RGD:11040540
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nos3
nitric oxide synthase 3, endothelial cell
treatment
ISO
RGD
PMID:29291552 PMID:18408363
RGD:13504682 , RGD:11040540
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Nox1
NADPH oxidase 1
treatment
ISO
RGD
PMID:34244746
RGD:329955363
NCBI chr X:132,987,170...133,038,455
Ensembl chr X:132,987,170...133,122,705
G
Nppa
natriuretic peptide type A
ISO
RGD
PMID:20471588
RGD:7247717
NCBI chr 4:148,085,179...148,086,531
Ensembl chr 4:148,085,179...148,086,536
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
treatment
ISO
RGD
PMID:21545725
RGD:11035217
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
severity
IEP IMP
mRNA:increased expression:kidney
RGD
PMID:22343121 PMID:22343121
RGD:14700869 , RGD:14700869
NCBI chr15:101,151,783...101,172,676
Ensembl chr15:101,152,150...101,172,676
G
Ogg1
8-oxoguanine DNA-glycosylase 1
ISO
RGD
PMID:12531391
RGD:2317150
NCBI chr 6:113,303,959...113,311,149
Ensembl chr 6:113,303,933...113,312,029
G
Pax2
paired box 2
ISO
mRNA, protein:increased expression:kidney
RGD
PMID:12444203
RGD:727468
NCBI chr19:44,735,040...44,826,708
Ensembl chr19:44,744,484...44,826,310
G
Pdgfb
platelet derived growth factor, B polypeptide
ISO
mRNA,protein:increased expression:tubule, S3 segment:
RGD
PMID:10550325
RGD:8554477
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
G
Pdgfra
platelet derived growth factor receptor, alpha polypeptide
ISO
mRNA:increased expression:kidney
RGD
PMID:10550325
RGD:8554477
NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876
G
Pdgfrb
platelet derived growth factor receptor, beta polypeptide
ISO
mRNA:increased expression:kidney
RGD
PMID:12819032 PMID:10550325
RGD:1580850 , RGD:8554477
NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
G
Peg10
paternally expressed 10
IEP
mRNA:increased expression:kidney (mouse)
RGD
PMID:16778176
RGD:401851077
NCBI chr 6:4,747,306...4,760,517
Ensembl chr 6:4,747,306...4,760,517
G
Pkd2
polycystin 2, transient receptor potential cation channel
ISO
protein:increased expression:kidney (rat)
RGD
PMID:12454224
RGD:1580868
NCBI chr 5:104,599,379...104,653,685
Ensembl chr 5:104,607,316...104,653,685
G
Ppargc1a
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha
treatment
ISO
RGD
PMID:24918615
RGD:10059636
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
G
Ptgis
prostaglandin I2 (prostacyclin) synthase
IEP
mRNA:increased expression:kidney (mouse)
RGD
PMID:30413885
RGD:401959745
NCBI chr 2:167,045,114...167,095,069
Ensembl chr 2:167,033,725...167,082,524
G
Rnls
renalase, FAD-dependent amine oxidase
ISO IEP IMP
mRNA,protein:decreased expression:kidney,plasma:
RGD
PMID:23393318 PMID:23393318 PMID:23393318
RGD:7327166 , RGD:7327166 , RGD:7327166
NCBI chr19:33,115,140...33,369,695
Ensembl chr19:33,115,147...33,369,665
G
Serpinc1
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1
severity
ISO
RGD
PMID:26108065 PMID:26108065
RGD:11354006 , RGD:11354006
NCBI chr 1:160,806,153...160,830,113
Ensembl chr 1:160,806,155...160,833,433
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Shh
sonic hedgehog
IEP
mRNA, protein:increased expression:kidney
RGD
PMID:24744439
RGD:12859042
NCBI chr 5:28,661,838...28,672,099
Ensembl chr 5:28,661,813...28,672,254
G
Sirt1
sirtuin 1
treatment
ISO
RGD
PMID:22324445
RGD:9495930
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
G
Six2
sine oculis-related homeobox 2
IEP
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr17:85,970,276...85,995,682
Ensembl chr17:85,991,705...85,995,702
G
Slc22a1
solute carrier family 22 (organic cation transporter), member 1
ISO
RGD
PMID:21835768
RGD:7243877
NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
G
Slc22a2
solute carrier family 22 (organic cation transporter), member 2
ISO
RGD
PMID:21835768
RGD:7243877
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
G
Slc34a1
solute carrier family 34 (sodium phosphate), member 1
ISO
protein:decreased expression:renal proximal tubule, brush border membrane (rat)
RGD
PMID:15775707
RGD:2311304
NCBI chr13:55,547,435...55,562,508
Ensembl chr13:55,546,000...55,563,405
G
Src
Rous sarcoma oncogene
ISO
RGD
PMID:12819032
RGD:1580850
NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782
G
Stat6
signal transducer and activator of transcription 6
severity
IMP
RGD
PMID:12709397
RGD:7244143
NCBI chr10:127,478,855...127,496,856
Ensembl chr10:127,478,855...127,496,826
G
Suz12
SUZ12 polycomb repressive complex 2 subunit
IEP
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr11:79,883,932...79,924,949
Ensembl chr11:79,883,932...79,924,949
G
Tfpi
tissue factor pathway inhibitor
ISO
RGD
PMID:11796005
RGD:11062062
NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119
G
Tgfb1
transforming growth factor, beta 1
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tlr2
toll-like receptor 2
treatment severity
ISO IDA IMP IEP
RGD
PMID:23239000 PMID:23023072 PMID:22750071 PMID:20130923 PMID:11801667
RGD:7207892 , RGD:7207894 , RGD:7207896 , RGD:7240552 , RGD:7241087
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr4
toll-like receptor 4
treatment
ISO IMP IEP
RGD
PMID:23239000 PMID:20130923 PMID:11801667
RGD:7207892 , RGD:7240552 , RGD:7241087
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tnf
tumor necrosis factor
ameliorates
ISO IEP
protein:increased expression:serum
RGD
PMID:19925291 PMID:24920753
RGD:2315112 , RGD:329845564
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
IEP
mRNA:increased expression:lung
RGD
PMID:22728466
RGD:7245543
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Vcam1
vascular cell adhesion molecule 1
ISO
protein:increased expression:kidney
RGD
PMID:20164827
RGD:7240507
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
G
Vwf
Von Willebrand factor
ISO
protein:increased expression:serum:
RGD
PMID:12684225
RGD:11080744
NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
G
Wt1
WT1 transcription factor
IEP
mRNA:altered expression:kidney (mouse)
RGD
PMID:18467665
RGD:155631277
NCBI chr 2:104,956,874...105,003,959
Ensembl chr 2:104,956,874...105,003,961
G
Xdh
xanthine dehydrogenase
treatment
ISO
associated with Diabetes Mellitus, Type 2
RGD
PMID:22995295 PMID:20616412
RGD:7247637 , RGD:7247695
NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
G
Zfp667
zinc finger protein 667
ameliorates
IEP
RGD
PMID:24920753
RGD:329845564
NCBI chr 7:6,289,187...6,310,882
Ensembl chr 7:6,289,578...6,310,882
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all